WAC 246-240-201   Use of unsealed radioactive material for which a written directive is required.  A licensee may use any unsealed radioactive material prepared for medical use and for which a written directive is required that is:

     (1) Obtained from a manufacturer or preparer licensed under WAC 246-235-100(1) or equivalent agreement state or U.S. NRC requirements; or

     (2) Prepared by an authorized nuclear pharmacist, a physician who is an authorized user and who meets the requirements specified in WAC 246-240-163 or 246-240-210, or an individual under the supervision of either as specified in WAC 246-240-057; or

     (3) Obtained from and prepared by an agreement state or U.S. NRC licensee for use in research in accordance with an investigational new drug (IND) protocol accepted by FDA; or

     (4) Prepared by the licensee for use in research in accordance with an investigational new drug (IND) protocol accepted by FDA.



[Statutory Authority: RCW 70.98.050. 06-05-019, § 246-240-201, filed 2/6/06, effective 3/9/06.]